About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit jagograhakjago.com
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit jagograhakjago.com
   India International Medical Equipment Expo - Delhi 1st Nov'2011
|
FDA approves Merck diabetes drug: OCT 7 : Juvisyn, a new drug produced by the Merck, has been approved by the US regulatory body, the Food and Drugs Administration (FDA). Juvisyn acts to both control blood sugar and reduce cholesterol. This two-in-one pill is a combination drug, comprising of (i) the cholesterol reducing medicine Simvastatin and (ii) Januvia, Merck’s diabetes drug, which was cleared for use along with diet and exercise in 2006. More than 20 million Americans have diabetes and shall be benefited by this drug.
Source: Fierce Biotech |
 |
|
© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065
jagograhakjago.com; jagograhakjago.com; Consumer Conexion
jagograhakjago.com; jagograhakjago.com; Consumer Conexion